{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T23:34:48Z","timestamp":1776209688064,"version":"3.50.1"},"reference-count":48,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"FCT\/MCTES","award":["UIDB\/50006\/2020"],"award-info":[{"award-number":["UIDB\/50006\/2020"]}]},{"name":"FCT\/MCTES","award":["UIDP\/50006\/2020"],"award-info":[{"award-number":["UIDP\/50006\/2020"]}]},{"name":"FCT\/MCTES","award":["UIDB\/\/04539\/2020"],"award-info":[{"award-number":["UIDB\/\/04539\/2020"]}]},{"name":"FCT\/MCTES","award":["UIDP\/\/04539\/2020"],"award-info":[{"award-number":["UIDP\/\/04539\/2020"]}]},{"name":"FCT\/MCTES","award":["LA\/P\/0058\/2020"],"award-info":[{"award-number":["LA\/P\/0058\/2020"]}]},{"name":"FCT\/MCTES","award":["UID\/DTP\/04138\/2020"],"award-info":[{"award-number":["UID\/DTP\/04138\/2020"]}]},{"name":"FCT\/MCTES","award":["UIDP\/04138\/2020"],"award-info":[{"award-number":["UIDP\/04138\/2020"]}]},{"name":"FCT\/MCTES","award":["EXPL\/MED-QUI\/0815\/2021"],"award-info":[{"award-number":["EXPL\/MED-QUI\/0815\/2021"]}]},{"name":"FCT\/MCTES","award":["PD\/BD\/145169\/2019"],"award-info":[{"award-number":["PD\/BD\/145169\/2019"]}]},{"name":"FCT\/MCTES","award":["UI\/BD\/154406\/2023"],"award-info":[{"award-number":["UI\/BD\/154406\/2023"]}]},{"name":"FCT\/MCTES","award":["2020.07432.BD"],"award-info":[{"award-number":["2020.07432.BD"]}]},{"name":"FCT\/MCTES","award":["2020.04126.CEECIND\/CP1596\/CT0006"],"award-info":[{"award-number":["2020.04126.CEECIND\/CP1596\/CT0006"]}]},{"name":"FCT\/MCTES","award":["SFRH\/BPD\/110001\/2015"],"award-info":[{"award-number":["SFRH\/BPD\/110001\/2015"]}]},{"name":"FCT\/MCTES","award":["DL57\/2016\/CP1334\/CT0006"],"award-info":[{"award-number":["DL57\/2016\/CP1334\/CT0006"]}]},{"name":"FCT\/MCTES","award":["LA\/P\/0008\/2020"],"award-info":[{"award-number":["LA\/P\/0008\/2020"]}]},{"name":"FCT","award":["UIDB\/50006\/2020"],"award-info":[{"award-number":["UIDB\/50006\/2020"]}]},{"name":"FCT","award":["UIDP\/50006\/2020"],"award-info":[{"award-number":["UIDP\/50006\/2020"]}]},{"name":"FCT","award":["UIDB\/\/04539\/2020"],"award-info":[{"award-number":["UIDB\/\/04539\/2020"]}]},{"name":"FCT","award":["UIDP\/\/04539\/2020"],"award-info":[{"award-number":["UIDP\/\/04539\/2020"]}]},{"name":"FCT","award":["LA\/P\/0058\/2020"],"award-info":[{"award-number":["LA\/P\/0058\/2020"]}]},{"name":"FCT","award":["UID\/DTP\/04138\/2020"],"award-info":[{"award-number":["UID\/DTP\/04138\/2020"]}]},{"name":"FCT","award":["UIDP\/04138\/2020"],"award-info":[{"award-number":["UIDP\/04138\/2020"]}]},{"name":"FCT","award":["EXPL\/MED-QUI\/0815\/2021"],"award-info":[{"award-number":["EXPL\/MED-QUI\/0815\/2021"]}]},{"name":"FCT","award":["PD\/BD\/145169\/2019"],"award-info":[{"award-number":["PD\/BD\/145169\/2019"]}]},{"name":"FCT","award":["UI\/BD\/154406\/2023"],"award-info":[{"award-number":["UI\/BD\/154406\/2023"]}]},{"name":"FCT","award":["2020.07432.BD"],"award-info":[{"award-number":["2020.07432.BD"]}]},{"name":"FCT","award":["2020.04126.CEECIND\/CP1596\/CT0006"],"award-info":[{"award-number":["2020.04126.CEECIND\/CP1596\/CT0006"]}]},{"name":"FCT","award":["SFRH\/BPD\/110001\/2015"],"award-info":[{"award-number":["SFRH\/BPD\/110001\/2015"]}]},{"name":"FCT","award":["DL57\/2016\/CP1334\/CT0006"],"award-info":[{"award-number":["DL57\/2016\/CP1334\/CT0006"]}]},{"name":"FCT","award":["LA\/P\/0008\/2020"],"award-info":[{"award-number":["LA\/P\/0008\/2020"]}]},{"DOI":"10.13039\/501100018886","name":"LAQV-REQUIMTE","doi-asserted-by":"publisher","award":["UIDB\/50006\/2020"],"award-info":[{"award-number":["UIDB\/50006\/2020"]}],"id":[{"id":"10.13039\/501100018886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018886","name":"LAQV-REQUIMTE","doi-asserted-by":"publisher","award":["UIDP\/50006\/2020"],"award-info":[{"award-number":["UIDP\/50006\/2020"]}],"id":[{"id":"10.13039\/501100018886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018886","name":"LAQV-REQUIMTE","doi-asserted-by":"publisher","award":["UIDB\/\/04539\/2020"],"award-info":[{"award-number":["UIDB\/\/04539\/2020"]}],"id":[{"id":"10.13039\/501100018886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018886","name":"LAQV-REQUIMTE","doi-asserted-by":"publisher","award":["UIDP\/\/04539\/2020"],"award-info":[{"award-number":["UIDP\/\/04539\/2020"]}],"id":[{"id":"10.13039\/501100018886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018886","name":"LAQV-REQUIMTE","doi-asserted-by":"publisher","award":["LA\/P\/0058\/2020"],"award-info":[{"award-number":["LA\/P\/0058\/2020"]}],"id":[{"id":"10.13039\/501100018886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018886","name":"LAQV-REQUIMTE","doi-asserted-by":"publisher","award":["UID\/DTP\/04138\/2020"],"award-info":[{"award-number":["UID\/DTP\/04138\/2020"]}],"id":[{"id":"10.13039\/501100018886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018886","name":"LAQV-REQUIMTE","doi-asserted-by":"publisher","award":["UIDP\/04138\/2020"],"award-info":[{"award-number":["UIDP\/04138\/2020"]}],"id":[{"id":"10.13039\/501100018886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018886","name":"LAQV-REQUIMTE","doi-asserted-by":"publisher","award":["EXPL\/MED-QUI\/0815\/2021"],"award-info":[{"award-number":["EXPL\/MED-QUI\/0815\/2021"]}],"id":[{"id":"10.13039\/501100018886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018886","name":"LAQV-REQUIMTE","doi-asserted-by":"publisher","award":["PD\/BD\/145169\/2019"],"award-info":[{"award-number":["PD\/BD\/145169\/2019"]}],"id":[{"id":"10.13039\/501100018886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018886","name":"LAQV-REQUIMTE","doi-asserted-by":"publisher","award":["UI\/BD\/154406\/2023"],"award-info":[{"award-number":["UI\/BD\/154406\/2023"]}],"id":[{"id":"10.13039\/501100018886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018886","name":"LAQV-REQUIMTE","doi-asserted-by":"publisher","award":["2020.07432.BD"],"award-info":[{"award-number":["2020.07432.BD"]}],"id":[{"id":"10.13039\/501100018886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018886","name":"LAQV-REQUIMTE","doi-asserted-by":"publisher","award":["2020.04126.CEECIND\/CP1596\/CT0006"],"award-info":[{"award-number":["2020.04126.CEECIND\/CP1596\/CT0006"]}],"id":[{"id":"10.13039\/501100018886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018886","name":"LAQV-REQUIMTE","doi-asserted-by":"publisher","award":["SFRH\/BPD\/110001\/2015"],"award-info":[{"award-number":["SFRH\/BPD\/110001\/2015"]}],"id":[{"id":"10.13039\/501100018886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018886","name":"LAQV-REQUIMTE","doi-asserted-by":"publisher","award":["DL57\/2016\/CP1334\/CT0006"],"award-info":[{"award-number":["DL57\/2016\/CP1334\/CT0006"]}],"id":[{"id":"10.13039\/501100018886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018886","name":"LAQV-REQUIMTE","doi-asserted-by":"publisher","award":["LA\/P\/0008\/2020"],"award-info":[{"award-number":["LA\/P\/0008\/2020"]}],"id":[{"id":"10.13039\/501100018886","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Type 2 diabetes mellitus (DM) continues to escalate, necessitating innovative therapeutic approaches that target distinct pathways and address DM complications. Flavonoids have been shown to possess several pharmacological activities that are important for DM. This study aimed to evaluate the in vivo effects of the flavonoid melanoxetin using Goto-Kakizaki rats. Over a period of 14 days, melanoxetin was administered subcutaneously to investigate its antioxidant, anti-inflammatory, and antidiabetic properties. The results show that melanoxetin reduced insulin resistance in adipose tissue by targeting protein tyrosine phosphatase 1B. Additionally, melanoxetin counteracted oxidative stress by reducing nitrotyrosine levels and modulating superoxide dismutase 1 and hemeoxygenase in adipose tissue and decreasing methylglyoxal-derived hydroimidazolone (MG-H1), a key advanced glycation end product (AGE) implicated in DM-related complications. Moreover, the glyoxalase 1 expression decreased in both the liver and the heart, correlating with reduced AGE levels, particularly MG-H1 in the heart. Melanoxetin also demonstrated anti-inflammatory effects by reducing serum prostaglandin E2 levels, and increasing the antioxidant status of the aorta wall through enhanced acetylcholine-dependent relaxation in the presence of ascorbic acid. These findings provide valuable insights into melanoxetin\u2019s therapeutic potential in targeting multiple pathways involved in type 2 DM, particularly in mitigating oxidative stress and glycation.<\/jats:p>","DOI":"10.3390\/pharmaceutics16020261","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T11:42:05Z","timestamp":1707478925000},"page":"261","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Melanoxetin: A Hydroxylated Flavonoid Attenuates Oxidative Stress and Modulates Insulin Resistance and Glycation Pathways in an Animal Model of Type 2 Diabetes Mellitus"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7786-2731","authenticated-orcid":false,"given":"S\u00f3nia","family":"Rocha","sequence":"first","affiliation":[{"name":"Associated Laboratory for Green Chemistry (LAQV), Network of Chemistry and Technology (REQUIMTE), Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0959-6571","authenticated-orcid":false,"given":"Andreia","family":"Amaro","sequence":"additional","affiliation":[{"name":"Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Clinical Academic Center of Coimbra (CACC), 3000-061 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0490-1212","authenticated-orcid":false,"given":"Marcos D.","family":"Ferreira-Junior","sequence":"additional","affiliation":[{"name":"Department of Physiological Sciences, Institute of Biological Sciences, University Federal of Goi\u00e1s, Goi\u00e2nia 74690-900, Brazil"}]},{"given":"Carina","family":"Proen\u00e7a","sequence":"additional","affiliation":[{"name":"Associated Laboratory for Green Chemistry (LAQV), Network of Chemistry and Technology (REQUIMTE), Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2861-8286","authenticated-orcid":false,"given":"Artur M. S.","family":"Silva","sequence":"additional","affiliation":[{"name":"LAQV, REQUIMTE, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0471-2756","authenticated-orcid":false,"given":"Vera M.","family":"Costa","sequence":"additional","affiliation":[{"name":"Research Unit on Applied Molecular Biosciences (UCIBIO), Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0423-7959","authenticated-orcid":false,"given":"Sara","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Clinical Academic Center of Coimbra (CACC), 3000-061 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8244-139X","authenticated-orcid":false,"given":"Diogo A.","family":"Fonseca","sequence":"additional","affiliation":[{"name":"Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9869-8651","authenticated-orcid":false,"given":"S\u00f3nia","family":"Silva","sequence":"additional","affiliation":[{"name":"Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6332-3937","authenticated-orcid":false,"given":"Maria Lu\u00edsa","family":"Corvo","sequence":"additional","affiliation":[{"name":"Research Institute for Medicines (iMed.ULisboa), Faculdade de Farm\u00e1cia, Universidade de Lisboa, 1649-003 Lisbon, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9114-9967","authenticated-orcid":false,"given":"Marisa","family":"Freitas","sequence":"additional","affiliation":[{"name":"Associated Laboratory for Green Chemistry (LAQV), Network of Chemistry and Technology (REQUIMTE), Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3422-290X","authenticated-orcid":false,"given":"Paulo","family":"Matafome","sequence":"additional","affiliation":[{"name":"Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Clinical Academic Center of Coimbra (CACC), 3000-061 Coimbra, Portugal"},{"name":"Coimbra Health School (ESTeSC), Polytechnic University of Coimbra, 3046-854 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6424-0976","authenticated-orcid":false,"given":"Eduarda","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Associated Laboratory for Green Chemistry (LAQV), Network of Chemistry and Technology (REQUIMTE), Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,9]]},"reference":[{"key":"ref_1","unstructured":"International Diabetes Federation (2023, December 13). IDF Diabetes Atlas 2021\u201410th Edition. Available online: https:\/\/diabetesatlas.org\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes\u20142023","volume":"46","author":"ElSayed","year":"2022","journal-title":"Diabetes Care"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41574-020-0334-z","article-title":"Young-onset type 2 diabetes mellitus\u2014Implications for morbidity and mortality","volume":"16","author":"Magliano","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s42255-022-00731-5","article-title":"A phenome-wide comparative analysis of genetic discordance between obesity and type 2 diabetes","volume":"5","author":"Coral","year":"2023","journal-title":"Nat. Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1038\/nrdp.2015.19","article-title":"Type 2 diabetes mellitus","volume":"16","author":"DeFronzo","year":"2015","journal-title":"Nat. Rev. Dis. Primers."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41419-017-0135-z","article-title":"Cellular death, reactive oxygen species (ROS) and diabetic complications","volume":"9","author":"Volpe","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jsps.2015.03.013","article-title":"Diabetes mellitus and oxidative stress\u2014A concise review","volume":"24","author":"Asmat","year":"2016","journal-title":"Saudi Pharm. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jbt.10058","article-title":"Diabetes, oxidative stress, and antioxidants: A review","volume":"17","author":"Maritim","year":"2003","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41574-022-00690-7","article-title":"The burden and risks of emerging complications of diabetes mellitus","volume":"18","author":"Tomic","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12933-022-01516-6","article-title":"Cardiovascular disease in type 2 diabetes mellitus: Progress toward personalized management","volume":"21","author":"Ma","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s43094-020-00151-w","article-title":"Diabetes and cardiovascular disease: Inter-relation of risk factors and treatment","volume":"6","author":"Sharma","year":"2020","journal-title":"Futur. J. Pharm. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2017.00006","article-title":"Clinical review of antidiabetic drugs: Implications for type 2 diabetes mellitus management","volume":"8","author":"Chaudhury","year":"2017","journal-title":"Front. Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e074068","DOI":"10.1136\/bmj-2022-074068","article-title":"Benefits and harms of drug treatment for type 2 diabetes: Systematic review and network meta-analysis of randomised controlled trials","volume":"381","author":"Shi","year":"2023","journal-title":"BMJ"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/s41574-021-00489-y","article-title":"Novel therapies with precision mechanisms for type 2 diabetes mellitus","volume":"17","author":"Perreault","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4239\/wjd.v5.i5.697","article-title":"Targeting inflammation in diabetes: Newer therapeutic options","volume":"5","author":"Agrawal","year":"2014","journal-title":"World J. Diabetes"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Burgos-Mor\u00f3n, E., Abad-Jim\u00e9nez, Z., Mart\u00ednez de Mara\u00f1\u00f3n, A., Iannantuoni, F., Escribano-L\u00f3pez, I., L\u00f3pez-Dom\u00e8nech, S., Salom, C., Jover, A., Mora, V., and Roldan, I. (2019). Relationship between oxidative stress, ER stress, and inflammation in type 2 diabetes: The battle continues. J. Clin. Med., 8.","DOI":"10.3390\/jcm8091385"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"806470","DOI":"10.3389\/fphar.2022.806470","article-title":"Dietary polyphenols and their role in oxidative stress-induced human diseases: Insights into protective effects, antioxidant potentials and mechanism(s) of action","volume":"13","author":"Rudrapal","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Al-Khayri, J.M., Sahana, G.R., Nagella, P., Joseph, B.V., Alessa, F.M., and Al-Mssallem, M.Q. (2022). Flavonoids as potential anti-inflammatory molecules: A review. Molecules, 27.","DOI":"10.3390\/molecules27092901"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"798329","DOI":"10.3389\/fphar.2021.798329","article-title":"Mechanisms underlying the antidiabetic activities of polyphenolic compounds: A review","volume":"12","author":"Nie","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1080\/10408398.2018.1492900","article-title":"Dietary polyphenols and type 2 diabetes: Human study and clinical trial","volume":"59","author":"Cao","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jtcme.2018.05.002","article-title":"A review of antioxidant and pharmacological properties of phenolic compounds in Acacia confusa","volume":"8","author":"Lin","year":"2018","journal-title":"J. Tradit. Complement. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5917","DOI":"10.1021\/jf050550m","article-title":"Phenolic Antioxidants from the Heartwood of Acacia confusa","volume":"53","author":"Wu","year":"2005","journal-title":"J. Agric. Food Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1021\/jf901498q","article-title":"Inhibition of xanthine oxidase by Acacia confusa extracts and their phytochemicals","volume":"58","author":"Tung","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9936","DOI":"10.1021\/jf102689k","article-title":"Phytochemicals from Acacia confusa heartwood extracts reduce serum uric acid levels in oxonate-induced mice: Their potential use as xanthine oxidase inhibitors","volume":"58","author":"Tung","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1021\/jf072922s","article-title":"Effect of phytocompounds from the heartwood of Acacia confusa on inflammatory mediator production","volume":"56","author":"Wu","year":"2008","journal-title":"J. Agric. Food Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1039\/D1FO02995A","article-title":"Inhibitory activity of flavonoids against human sucrase-isomaltase (\u03b1-glucosidase) activity in a Caco-2\/TC7 cellular model","volume":"13","author":"Rufino","year":"2022","journal-title":"Food Funct."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1080\/14756366.2017.1368503","article-title":"\u03b1-Glucosidase inhibition by flavonoids: An in vitro and in silico structure-activity relationship study","volume":"32","author":"Freitas","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_28","first-page":"329","article-title":"Antimicrobial, cytotoxic and oxidative stress inhibitory activities of terpenoids and flavonols from Senegalia nigrescens (Oliv.) P.J.H. Hurter","volume":"20","author":"Bodede","year":"2021","journal-title":"Iran J. Pharm. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejmech.2016.04.057","article-title":"New polyhydroxylated flavon-3-ols and 3-hydroxy-2-styrylchromones: Synthesis and ROS\/RNS scavenging activities","volume":"119","author":"Sousa","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.phrs.2012.03.004","article-title":"Methylglyoxal promotes oxidative stress and endothelial dysfunction","volume":"65","author":"Sena","year":"2012","journal-title":"Pharmacol. Res."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Akpoveso, O.-O.P., Ubah, E.E., and Obasanmi, G. (2023). Antioxidant phytochemicals as potential therapy for diabetic complications. Antioxidants, 12.","DOI":"10.3390\/antiox12010123"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Guest, P.C. (2019). Pre-Clinical Models: Techniques and Protocols, Springer.","DOI":"10.1007\/978-1-4939-8994-2"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"101882","DOI":"10.1016\/j.eclinm.2023.101882","article-title":"Pharmacotherapy of obesity: An update on the available medications and drugs under investigation","volume":"58","author":"Chakhtoura","year":"2023","journal-title":"eClinicalMedicine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.ijbiomac.2021.04.061","article-title":"Pyrazoles as novel protein tyrosine phosphatase 1B (PTP1B) inhibitors: An in vitro and in silico study","volume":"181","author":"Rocha","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"585887","DOI":"10.3389\/fendo.2021.585887","article-title":"Leptin and obesity: Role and clinical implication","volume":"12","author":"Obradovic","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1080\/10408398.2021.1872483","article-title":"A comprehensive review on the antidiabetic activity of flavonoids targeting PTP1B and DPP-4: A structure-activity relationship analysis","volume":"62","author":"Ribeiro","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Letra, L., and Sei\u00e7a, R. (2017). Obesity and Brain Function, Springer International Publishing.","DOI":"10.1007\/978-3-319-63260-5"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.freeradbiomed.2022.03.019","article-title":"Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives","volume":"184","author":"Bhatti","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Lai, K.N., and Tang, S.C.W. (2011). Diabetes and the Kidney, S.Karger AG.","DOI":"10.1159\/isbn.978-3-8055-9743-2"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s001250100529","article-title":"Detection of nitrotyrosine in the diabetic plasma: Evidence of oxidative stress","volume":"44","author":"Ceriello","year":"2001","journal-title":"Diabetologia"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2337\/diacare.25.8.1439","article-title":"Role of hyperglycemia in nitrotyrosine Postprandial Generation","volume":"25","author":"Ceriello","year":"2002","journal-title":"Diabetes Care"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Khalid, M., Petroianu, G., and Adem, A. (2022). Advanced glycation end products and diabetes mellitus: Mechanisms and perspectives. Biomolecules, 12.","DOI":"10.3390\/biom12040542"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"116526","DOI":"10.1016\/j.bone.2022.116526","article-title":"Methylglyoxal\u2014An advanced glycation end products (AGEs) precursor\u2014Inhibits differentiation of human MSC-derived osteoblasts in vitro independently of receptor for AGEs (RAGE)","volume":"164","author":"Waqas","year":"2022","journal-title":"Bone"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1042\/CS20220099","article-title":"Methylglyoxal and glyoxalase 1\u2014A metabolic stress pathway-linking hyperglycemia to the unfolded protein response and vascular complications of diabetes","volume":"136","author":"Rabbani","year":"2022","journal-title":"Clin. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Fenske, R.J., Weeks, A.M., Daniels, M., Nall, R., Pabich, S., Brill, A.L., Peter, D.C., Punt, M., Cox, E.D., and Davis, D.B. (2022). Plasma prostaglandin e2 metabolite levels predict type 2 diabetes status and one-year therapeutic response independent of clinical markers of inflammation. Metabolites, 12.","DOI":"10.3390\/metabo12121234"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Wang, M.-H., Hsiao, G., and Al-Shabrawey, M. (2020). Eicosanoids and oxidative stress in diabetic retinopathy. Antioxidants, 9.","DOI":"10.3390\/antiox9060520"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.fob.2015.06.001","article-title":"Reactive oxygen species induce Cox-2 expression via TAK1 activation in synovial fibroblast cells","volume":"5","author":"Onodera","year":"2015","journal-title":"FEBS Open Bio."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/16\/2\/261\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:58:04Z","timestamp":1760104684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/16\/2\/261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,9]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["pharmaceutics16020261"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics16020261","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,9]]}}}